TITLE

QRXPHARMA BEGINS PHASE III CLINICAL TRIAL FOR PAIN THERAPY

PUB. DATE
January 2008
SOURCE
Worldwide Biotech;Jan2008, Vol. 20 Issue 1, p1
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports on the Phase III clinical trial conducted by QRxPharma for its lead product candidate Q8003IR, an immediate release dual-opioid pain therapy. The trial involved a double-blind, placebo-controlled study that aims to compare the efficacy and safety of four different dosage strengths of Q8003IR versus placebo in a post-surgery, acute pain setting.
ACCESSION #
28025758

 

Related Articles

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics